Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
02/1996
02/01/1996CA2191975A1 Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis
01/1996
01/31/1996EP0694546A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
01/31/1996EP0694545A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
01/31/1996EP0693921A1 Anti-oxidant alkylaryl polyether alcohol polymers
01/31/1996EP0608353B1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES
01/31/1996EP0593615B1 Aromatic compounds, compositions containing them and their use in therapy
01/30/1996US5488062 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
01/30/1996CA2031572C Non-alcoholic delivery system for orally ingestible active ingredients
01/26/1996CA2154129A1 Endothelin-antagonizing peptide
01/25/1996WO1996001825A1 Heterobicyclic derivatives
01/25/1996WO1996001819A1 Heterocyclic tachykinin receptor antagonists
01/25/1996WO1996001817A1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
01/25/1996CA2194872A1 Pyridopyrazine derivatives
01/25/1996CA2188680A1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
01/24/1996EP0693489A1 Heterocyclic tachykinin receptor antagonists
01/24/1996EP0693059A1 Perhydroisoindole derivatives, preparation thereof and pharmaceutical compositions containing same
01/24/1996EP0693053A1 Urea and amide derivatives and their use in the control of cell membrane potassium channels
01/24/1996EP0692984A1 Systemic effects of nitric oxide inhalation
01/24/1996EP0692970A1 Method for reducing the viscosity of pathological mucoid airway contents in the respiratoy tract
01/24/1996EP0692963A1 Use of terbinafine for the therapeutic treatment of pneumocystosis
01/24/1996EP0663830A4 Method of treating lung disease with uridine triphosphates.
01/23/1996US5486529 Certain pyridyl ketones for treating diseases involving leukocyte elastase
01/23/1996US5486525 Platelet activating factor antagonists: imidazopyridine indoles
01/23/1996US5486510 Method and compositions for modulating or control of immune responses in humans
01/23/1996US5485827 Providing nitrogen oxide for breathing
01/23/1996CA2154116A1 1-aryl-2-acetamidopentanone derivatives for use as tachykinin receptor antagonists
01/23/1996CA1337991C Basically substituted phenylacetonitriles, their preparation and drugs containing these compounds
01/18/1996DE4424714A1 Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff New chemical compound, their preparation and their use as Arnzneistoff
01/18/1996DE4424713A1 Substituierte Benzamidine, ihre Herstellung und Verwendung als Arnzneistoffe Substituted benzamidines, their preparation and use as Arnzneistoffe
01/17/1996EP0692472A1 Alpha-(4-chlorophenyl)- 4-(4-fluorophenylmethyl)-piperidine-1 -ethanol esters, their preparation and therapeutical use
01/17/1996EP0692251A1 Use of methotrexate for the manufacture of a medicament for the treatment of lung capillary leak
01/17/1996EP0691985A1 Phosphonomethyldipeptides
01/17/1996EP0691966A1 Quinolines as type iv phosphodiesterase inhibitors
01/17/1996EP0691842A1 Lidocaine aerosol anaesthetic
01/17/1996EP0554381B1 Use of protective agents against reactive oxygen species
01/17/1996CN1114961A Peptide inhibitors of cell adhesion
01/17/1996CN1114957A New (thia)cycloalkyl|b¨indole compounds, process for the preparation thereof, and pharmaceutical compositions containing them
01/17/1996CN1030718C Superoxide dismutase
01/17/1996CN1030703C Neurokinin A antagonists
01/16/1996US5484805 Heterocyclene derivatives
01/16/1996US5484804 Perhydroisoindole derivatives as antagonists of substance P
01/14/1996CA2153726A1 .alpha.-(4-chlorophenyl)-4-[(4-fluorophenyl)-methyl]piperidine-1- ethanol esters, their preparation and their therapeutic application
01/11/1996WO1996000738A1 Endothelin antagonists ii
01/11/1996WO1996000732A1 Phosphinic acid derivatives
01/11/1996WO1996000725A1 (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants
01/11/1996WO1996000581A1 Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin
01/11/1996WO1996000580A1 Health composition
01/11/1996WO1996000579A1 Aqueous cell extracts and aqueous suspensions of cell wall fractions from mycobacteria
01/11/1996DE4422859A1 Wäßrige Zellextrakte und wäßrige Suspensionen von Zellwandfraktionen aus Mykobacterien Aqueous cell extracts and aqueous suspensions of cell wall fractions from mycobacteriae
01/11/1996CA2194138A1 Aqueous cell extracts and aqueous suspensions of cell wall fractions from mycobacteria
01/11/1996CA2193828A1 Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin
01/11/1996CA2193367A1 (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants
01/11/1996CA2190756A1 Endothelin antagonists ii
01/10/1996EP0691401A1 Human manganese superoxide dismutase analogs, pharmaceutical compositions containing them, and use thereof
01/10/1996EP0690850A1 2-substituted morpholine and thiomorpholine derivatives as gaba-b antagonists
01/10/1996EP0690849A1 Heterocycle-containing amidine derivatives, their preparation and use
01/10/1996EP0613470B1 Novel 4-cinnolinone derivatives, their preparation and application in therapy
01/10/1996CN1114564A New medicine for curing vascular system disease
01/09/1996US5482963 Pharmaceutical agents useful as leukotriene antagonists
01/09/1996US5482960 Nonpeptide endothelin antagonists
01/09/1996US5482948 Pyridyl derivatives and pharmaceutical compositions comprising these compounds
01/09/1996US5482942 (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants
01/09/1996US5482941 Quinazolinone antianginal agents
01/09/1996CA2013895C Substituted 1-¬3-(heteroarylmethoxy)phenyl|alkanols and related compounds in the treatment of asthma, arthritis and related diseases
01/04/1996WO1996000218A1 Compounds for and method of inhibiting phosphodiesterase iv
01/04/1996WO1995033467A3 Modulators of pneumococcal adherence to pulmonary and vascular cells and diagnostic and therapeutic applications
01/04/1996CA2193725A1 Aryl derivative compounds and uses to inhibit phosphodiesterase iv acti vity
01/03/1996EP0690050A1 (Thia)cycloalkyl(b) indole derivatives as 5-lipoxygenase inhibitors
01/03/1996EP0689592A1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
01/03/1996EP0619806B1 Preparation of substituted piperidines
01/03/1996EP0587790B1 Non-chlorofluorocarbon aerosol formulations
01/03/1996EP0513104B1 USE OF AN alpha-tocoPHEROL PHOSPHATE OR A DERIVATIVE THEREOF FOR PREPARING COSMETIC, DERMATOLOGICAL OR PHARMACEUTICAL COMPOSITIONS, AND COMPOSITIONS THEREBY OBTAINED
01/03/1996CN1114318A Novel purine derivatives and pharmaceutically acceptable salts thereof
01/03/1996CN1114310A 1H-indole-3-glyoxylamide spla2 inhibitors
01/02/1996US5481043 Phenone compounds, manufacturing method and pharmaceutical preparations containing them
01/02/1996CA2152981A1 Method of attenuating lung capillary leak in a mammal
12/1995
12/29/1995CA2152725A1 (thia)cycloalkyl [b] indoles; process for preparing the same and pharmaceutical compositions containing them
12/28/1995WO1995035375A1 Interleukin-5 specific recombinant antibodies
12/28/1995WO1995035372A1 5-lipoxygenase-activating protein ii
12/28/1995WO1995035292A1 Antiviral agent containing benzodithiin derivative as active ingredient
12/28/1995WO1995035284A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
12/28/1995WO1995035281A1 Tri-substituted phenyl derivates useful as pde iv inhibitors
12/28/1995WO1995035279A1 Substituted alkyldiamine derivatives and their use as tachykinin antagonists
12/28/1995WO1995035103A1 A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof
12/28/1995WO1995014713A3 Abundant extracellular products and methods for their production and use
12/28/1995CA2193496A1 Antiviral agent containing benzodithiin derivative as active ingredient
12/28/1995CA2193396A1 A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof
12/27/1995EP0688337A1 Compositions and methods for the treatment of immunomediated inflammatory disorders
12/27/1995EP0607178A4 Methods for the selection, separation and fusion of cells.
12/27/1995EP0418230B1 Method for potentiating and inhibiting insulin-like growth factor activity
12/26/1995US5478942 Cyclic urea derivatives and pharmaceutical compositions containing these compounds
12/26/1995US5478941 Enantiomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl) sulfonyl]piperazine
12/26/1995US5478938 Antagonists for angiotensin II receptors; hypotensive, cardiotonic agents; cognitive activators
12/26/1995US5478858 Respiratory system disorders, gastrointestinal disorders
12/26/1995US5478856 Styrene derivatives and salts thereof
12/26/1995US5478842 Antiinflammatory agents, antiallergens, drugs for treatment of diseases mediated by leukotrienes
12/26/1995US5478573 Delayed, sustained-release propranolol pharmaceutical preparation
12/26/1995CA2021534C Antiallergic spray preparations
12/21/1995WO1995034556A1 Cyclobut-3-ene-1,2-dione derivatives as smooth muscle relaxants
12/21/1995WO1995034324A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin